Literature DB >> 8093581

Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.

V Chan-Palay1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093581

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  8 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 2.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 3.  Depression in Parkinson disease--epidemiology, mechanisms and management.

Authors:  Dag Aarsland; Sven Påhlhagen; Clive G Ballard; Uwe Ehrt; Per Svenningsson
Journal:  Nat Rev Neurol       Date:  2011-12-26       Impact factor: 42.937

4.  Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

Authors:  V Klimek; C Stockmeier; J Overholser; H Y Meltzer; S Kalka; G Dilley; G A Ordway
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 5.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

Review 6.  Therapeutic potentials of human embryonic stem cells in Parkinson's disease.

Authors:  Mary B Newman; Roy A E Bakay
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 7.  Noradrenergic Modulation of Cognition in Health and Disease.

Authors:  Olga Borodovitsyna; Matthew Flamini; Daniel Chandler
Journal:  Neural Plast       Date:  2017-05-03       Impact factor: 3.599

8.  Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibition.

Authors:  Melanie Clarke; Rowan Pentz; Jessica Bobyn; Shawn Hayley
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.